Showing results (381-390 of 492) with videos related to
Sort By:
Pageof 50
Haematologica|May 11, 2019
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemiaSalih Demir, Elena Boldrin, Qian Sun, et al.Critical Reviews in Oncogenesis|December 6, 2016
Cell Death Induction in Cancer Therapy - Past, Present, and FutureLisa Nonnenmacher, Sebastian Hasslacher, Julia Zimmermann, et al.Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.Pancreas|September 6, 2013
Absence of FLICE-inhibitory protein is a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinomaSandra J Schmid, Marie-Charlotte Glatzel, Claudia Welke, et al.Oncogene|March 13, 2020
Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cellsCathinka Boedicker, Michelle Hussong, Christina Grimm, et al.Molecular Immunology|January 17, 2012
Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitroMarkus Huber-Lang, Stephanie Denk, Simone Fulda, et al.Frontiers in Oncology|October 16, 2018
Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K InhibitorsNatalie Geyer, Rosalie Ridzewski, Julia Bauer, et al.Vaccines|August 28, 2021
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed SubjectsDorit Fabricius, Carolin Ludwig, Judith Scholz, et al.Cell Death & Disease|July 3, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylationStefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, et al.Frontiers in Pediatrics|July 18, 2022
Pulmonary Function and Persistent Clinical Symptoms in Children and Their Parents 12 Months After Mild SARS-CoV-2 InfectionSebastian F N Bode, Marisa Haendly, Dorit Fabricius, et al.Pageof 50